BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19131945)

  • 1. Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood.
    Novelli M; Merlino C; Ponti R; Bergallo M; Quaglino P; Cambieri I; Comessatti A; Sidoti F; Costa C; Corino D; Cavallo R; Ponzi AN; Fierro MT; Bernengo MG
    J Invest Dermatol; 2009 Jun; 129(6):1556-61. PubMed ID: 19131945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.
    Haverkos BM; Gru AA; Geyer SM; Bingman AK; Hemminger JA; Mishra A; Wong HK; Pancholi P; Freud AG; Caligiuri MA; Baiocchi RA; Porcu P
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl(Suppl):S181-S190.e4. PubMed ID: 27521316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides.
    Shimakage M; Sasagawa T; Kawahara K; Yutsudo M; Kusuoka H; Kozuka T
    Int J Cancer; 2001 Apr; 92(2):226-31. PubMed ID: 11291050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of EBER nuclear RNA in T-cell lymphomas involving the skin--an in situ hybridization study.
    Park CK; Ko YH
    Br J Dermatol; 1996 Mar; 134(3):488-93. PubMed ID: 8731674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of Epstein-Barr viral encoded RNA (EBER) in primary cutaneous t-cell lymphoma.
    Angel CA; Slater DN; Royds JA; Nelson SN; Bleehen SS
    J Pathol; 1996 Feb; 178(2):173-5. PubMed ID: 8683385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epstein-Barr virus research by in situ hybridization in 65 cutaneous T cell epidermotropic lymphomas].
    Jumbou O; Huet S; Bureau B; Litoux P; Dréno B
    Ann Dermatol Venereol; 1998 Feb; 125(2):90-3. PubMed ID: 9747220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations.
    Anagnostopoulos I; Hummel M; Kaudewitz P; Korbjuhn P; Leoncini L; Stein H
    Br J Dermatol; 1996 Feb; 134(2):276-81. PubMed ID: 8746341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sézary syndrome.
    Dreno B; Celerier P; Fleischmann M; Bureau B; Litoux P
    Acta Derm Venereol; 1994 Sep; 74(5):355-7. PubMed ID: 7817670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aggressive cutaneous T-cell lymphoma associated with the presence of Epstein-Barr virus. 2 cases].
    Mouly F; Baccard M; Rybojad M; Lebbé C; Morinet F; Morel P
    Ann Dermatol Venereol; 1996; 123(9):574-6. PubMed ID: 9615113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous angioimmunoblastic T-cell lymphoma: Epstein-Barr virus positivity and its effects on clinicopathologic features.
    Lee WJ; Won KH; Choi JW; Won CH; Chang SE; Choi JH; Lee MW
    J Am Acad Dermatol; 2019 Oct; 81(4):989-997. PubMed ID: 30240776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role.
    Ponti R; Bergallo M; Costa C; Quaglino P; Fierro MT; Comessatti A; Stroppiana E; Sidoti F; Merlino C; Novelli M; Alotto D; Cavallo R; Bernengo MG
    Br J Dermatol; 2008 Nov; 159(5):1131-7. PubMed ID: 18782321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
    Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
    J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
    Park S; Lee DY; Kim WS; Ko YH
    Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus.
    Kanavaros P; Ioannidou D; Tzardi M; Datseris G; Katsantonis J; Delidis G; Tosca A
    Pathol Res Pract; 1994 Sep; 190(8):767-74. PubMed ID: 7831152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic characteristics of primary cutaneous T-cell lymphoma in Korea.
    Kim JE; Huh J; Cho K; Kim CW
    J Korean Med Sci; 1998 Feb; 13(1):31-8. PubMed ID: 9539316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
    Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
    APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.